- Home
- NOTV vs DLHC Comparison
NOTV vs DLHC Comparison
Compare NOTV & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- DLHC
- Stock Information
- Founded
- NOTV 1974
- DLHC 1969
- Country
- NOTV United States
- DLHC United States
- Employees
- NOTV N/A
- DLHC N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- DLHC Business Services
- Sector
- NOTV Health Care
- DLHC Consumer Discretionary
- Exchange
- NOTV Nasdaq
- DLHC Nasdaq
- Market Cap
- NOTV 57.7M
- DLHC 79.7M
- IPO Year
- NOTV 1997
- DLHC N/A
- Fundamental
- Price
- NOTV $1.69
- DLHC $5.58
- Analyst Decision
- NOTV Strong Buy
- DLHC
- Analyst Count
- NOTV 1
- DLHC 0
- Target Price
- NOTV $5.00
- DLHC N/A
- AVG Volume (30 Days)
- NOTV 429.6K
- DLHC 32.9K
- Earning Date
- NOTV 08-06-2025
- DLHC 08-06-2025
- Dividend Yield
- NOTV N/A
- DLHC N/A
- EPS Growth
- NOTV N/A
- DLHC 80.25
- EPS
- NOTV N/A
- DLHC 0.31
- Revenue
- NOTV $505,299,000.00
- DLHC $359,723,000.00
- Revenue This Year
- NOTV $5.64
- DLHC N/A
- Revenue Next Year
- NOTV $5.16
- DLHC N/A
- P/E Ratio
- NOTV N/A
- DLHC $17.75
- Revenue Growth
- NOTV 0.85
- DLHC N/A
- 52 Week Low
- NOTV $1.15
- DLHC $2.72
- 52 Week High
- NOTV $6.48
- DLHC $11.16
- Technical
- Relative Strength Index (RSI)
- NOTV 41.79
- DLHC 51.10
- Support Level
- NOTV $1.65
- DLHC $5.50
- Resistance Level
- NOTV $1.85
- DLHC $5.60
- Average True Range (ATR)
- NOTV 0.13
- DLHC 0.14
- MACD
- NOTV -0.01
- DLHC 0.00
- Stochastic Oscillator
- NOTV 8.33
- DLHC 20.00
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.